Landscape for Lung Cancer Therapies is Focus of New Post-ASCO - Forbes
SCOTTSDALE, Ariz., June 26 /PRNewswire/ — MedPredict has published a new report in its oncology series entitled “Thought Leader Insight & Analysis: Lung Cancer,” designed to provide critical strategic insight for pharma and biotech companies with a
Cuba Announces Lung Cancer Vaccine - Digital Chosunilbo
Cuban scientists have announced a new vaccine they say extends the lives of lung cancer patients by up to five months. Scientist Gisela Gonzalez said Tuesday in Havana that the product, called CimaVax EGF, is the first registered vaccine in the world
Cuba approves, makes available lung cancer vaccine - Reuters UK
HAVANA (Reuters) - Cuban scientists said on Tuesday the first vaccine to extend lives of lung cancer patients has been approved by Cuban authorities for use and is available in the island’s hospitals. The drug, CimaVax EGF, has been shown to increase
Cuban lung cancer vaccine boosts patient survival - Xinhua News Agency
BEIJING, June 25 (Xinhuanet) — A vaccine that Cuban scientists extends the lives of lung cancer patients has been approved for use by Cuban authorities and is available in the island’s hospitals. The drug, CimaVax EGF, has been shown to increase
New clinical trial for patients with asbestos-associated lung cancer - News-Medical.Net
The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and
Lung Cancer Alliance Hails Landmark Legislation - Forbes
WASHINGTON , June 25 /PRNewswire-USNewswire/ — Today, Lung Cancer Alliance (LCA) hailed the introduction of legislation that creates the first ever multi-agency, comprehensive program targeted at lung cancer and authorizes $75 million to start the
Latest cancer drug off NHS list as Roche refuses to supply data - Financial Times
British patients will lose the chance of treatment with Roche’s latest and most expensive cancer medicine after the Swiss pharmaceuticals group refused to cooperate with the government’s medicines advisory body. The National Institute for Clinical